Prof. Dr. Wolfram Wirbelauer is a trustberg. partner and lawyer admitted to the German bar.
​
Having studied at the universities of Mainz, Jena, Gießen, and Liverpool and received his Ph.D. in legal history, he has worked with major international organizations, such as PwC, KayeScholer, Covington & Burling, and BusinessEurope.
​
At trustberg. Prof. Dr. Wirbelauer focuses on individual and collective labor law, compliance, and employee data protection law. He speaks English and German.
vita.
-
Law studies in Mainz, Jena, and Gießen
​
-
Studies in Business Administration in Liverpool
​
-
Admission to the German bar, 2009
​
-
Ph.D. in legal history, 2012
​
-
Appointment as Professor of Business Law, 2018
​
​
focus.
-
Individual and collective labor law
​
-
Compliance
​
-
Employee data protection law
​
-
Legal advice and court representation
track record.
-
Legal assessment in German labor and social security law on a stock options plan drafted for a European telecommunication company
​
-
Representation of a medical center’s chief physician before the employment courts
​
-
Compliance investigation and legal assessment in industrial constitution law for an international software company
​
-
Dismissal protection trial representation for an executive employee of a supra-regional advertising agency
​
-
Drafting of a legal fact book as a part of a sales and purchase procedure concerning the purchase of a Dax 30 company´s international sub-companies
​
-
Legal advice and drafting of employee secondment contracts and corporate immigration procedures for a U.S. American global player in soft drink production and sales​​​
​
-
Legal advice and drafting of termination agreements for the CEO of an Asian sub-company of a German pharmaceutical company
​
-
Legal due diligence assessment within a sale and purchase procedure concerning the acquisition of a group of hotels by an American investor
​
-
Dismissal protection trial for the head of compliance of an international weapons manufacturer
​
-
Negotiation of a company bargaining agreement for an international pharmaceutical company as part of a post-merger integration

